Catalyst Wire Dossier Catalyst Wire Dossier

Nintedanib

nintedanib · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

102 regulatory and trial events tracked for Nintedanib, covering 2009-08-21 to 2026-08-13. Get the full timeline:

Most recent: Clinical Trial Results: Study to Determine Potential for Drug-drug Interactions When Co-administering Deupirfenidone (LYT-100) and Nintedanib [Phase 1]

See pricing